The development of Inflammatory Bowel Disease (IBD) may be influenced through a protein in the gut leading to inflammation according to research.
The Biomedical and Life Sciences (BLS) Division is opening its doors to artists who want to explore the theory and practice of microbiological processes.
New drugs for diseases like cystic fibrosis could be developed following a £1.5m grant to a research team led by Lancaster University.
Lancaster University is launching an online course on the Ebola virus in response to the largest ever outbreak of the disease.
Students and staff this week witnessed a significant development in the construction of two new super-labs providing teaching space for more than 200 students.
A new study, published in Neuropharmacology and conducted by academics at Lancaster University, could bring substantial improvements in the treatment of Alzheimer's disease by using drugs currently on the market to treat type 2 diabetes.
Lancaster University will play an important part in the region’s efforts to tackle dementia.
Humans may be exposed to bacteria linked with Crohn’s disease through fine spray from showers and rivers according to research led by Lancaster University.
The Leishmania parasite, which causes the human disease leishmaniasis, acts as a probiotic in the insect that transmits it to humans, protecting them from bacterial disease.
Lancaster has been ranked ninth in the UK for Biosciences, in the Guardian University Guide 2015.